4DMedical Limited
4DMedical Limited (FDMDF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
fdmdf · pe ratio · data through Jun 30, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for 4DMedical Limited (FDMDF) measures how much investors pay for each dollar of the company's trailing earnings. FDMDF's current PE ratio of N/A is calculated by dividing its stock price of $2.66 by its TTM earnings per share of -$0.32.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-06-30
PE Ratio History
2014 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
4DMedical LimitedYou FDMDF | $1.6B | N/A | — | -$0.32 |
 Allergy Therapeutics plc AGYTF | $655M | N/A | — | -$0.01 |
 Beijing Tong Ren Tang Chinese Medicine Company Limited BJTRF | $536M | 10.64x | -67.7% | $0.47 |
 PolyNovo Limited CALZF | $415M | 64.01x | +94.3% | $0.02 |
 CellaVision AB (publ) CLVSF | $322M | 24.18x | -26.6% | $6.42 |
 Avisa Diagnostics Inc. FOGCF | $0M | N/A | — | -$0.14 |
 GenSight Biologics S.A. GSGTF | $31M | N/A | — | -$0.08 |
Industry Average 3 peers with valid PE | — | 32.94x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-06-30Latest FY2025 | — | $-0.14 | — | |
2024-06-30 FY2024 | — | $-0.11 | — | |
2023-06-30 FY2023 | — | $-0.10 | — | |
2022-06-30 FY2022 | — | $-0.08 | — | |
2021-06-30 FY2021 | — | $-0.08 | — | |
2020-06-30 FY2020 | — | $-0.08 | — | |
2019-06-30 FY2019 | — | $-0.04 | — | |
2018-06-30 FY2018 | — | $-0.03 | — | |
2017-06-30 FY2017 | — | $-0.03 | — | |
2015-12-31 FY2015 | — | $-32.77 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for 4DMedical Limited (FDMDF) measures how much investors pay for each dollar of the company's trailing earnings. FDMDF's current PE ratio of N/A is calculated by dividing its stock price of $2.66 by its TTM earnings per share of -$0.32.
Frequently asked questions
FDMDF pe ratio · 6 questionsFDMDF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $2.66 and TTM EPS of -$0.32. Data sourced from Financial Modeling Prep via FDMDF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · 4DMedical Limited SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09